Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,197,780
  • Shares Outstanding, K 226,109
  • Annual Sales, $ 130,510 K
  • Annual Income, $ -181,220 K
  • 60-Month Beta 1.43
  • Price/Sales 17.52
  • Price/Cash Flow N/A
  • Price/Book 3.63
Trade PACB with:

Options Overview Details

View History
  • Implied Volatility 100.76% ( -6.58%)
  • Historical Volatility 109.60%
  • IV Percentile 26%
  • IV Rank 19.76%
  • IV High 379.80% on 07/08/22
  • IV Low 32.06% on 07/01/22
  • Put/Call Vol Ratio 0.70
  • Today's Volume 759
  • Volume Avg (30-Day) 6,085
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 75,597
  • Open Int (30-Day) 90,673

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.34
  • Number of Estimates 3
  • High Estimate -0.34
  • Low Estimate -0.35
  • Prior Year -0.30
  • Growth Rate Est. (year over year) -13.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.65 +23.53%
on 11/04/22
12.37 -23.61%
on 11/15/22
+0.73 (+8.37%)
since 10/28/22
3-Month
4.97 +90.14%
on 09/29/22
12.37 -23.61%
on 11/15/22
+3.62 (+62.09%)
since 08/29/22
52-Week
3.85 +145.45%
on 06/14/22
23.87 -60.41%
on 11/29/21
-13.87 (-59.48%)
since 11/26/21

Most Recent Stories

More News
PacBio to Present at Upcoming Investor Conferences

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating...

PACB : 9.45 (-2.78%)
PacBio's (PACB) Q3 Earnings Top Estimates, Revenues Lag

PacBio (PACB) witnesses strength in Service and other revenues, along with robust consumable sales, in the third quarter.

MMSI : 70.13 (-0.04%)
AMN : 122.01 (-0.78%)
PACB : 9.45 (-2.78%)
MEDP : 207.24 (-2.54%)
Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 8.57% and 8.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

PACB : 9.45 (-2.78%)
ASXC : 0.4001 (-2.41%)
Pacific Biosciences: Q3 Earnings Snapshot

Pacific Biosciences: Q3 Earnings Snapshot

PACB : 9.45 (-2.78%)
PacBio Announces Third Quarter 2022 Financial Results

/PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2022. Third quarter results Revenue of $32.3...

PACB : 9.45 (-2.78%)
PacBio Announces that Euan Ashley, M.D., Ph.D., Joseph Puglisi, Ph.D., and Jay Shendure, Ph.D., Join Newly Created Scientific Advisory Board

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it is bringing together a...

PACB : 9.45 (-2.78%)
LivaNova (LIVN) Beats Q3 Earnings and Revenue Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 1.75% and 2.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LIVN : 52.93 (+1.01%)
PACB : 9.45 (-2.78%)
PacBio Announces Revio, a Revolutionary New Long Read Sequencing System Designed to Provide 15 Times More HiFi Data and Human Genomes at Scale for Under $1,000

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Revio™ long-read...

PACB : 9.45 (-2.78%)
PacBio Announces Onso, the Highly Accurate Short-Read Sequencing Platform

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the commencement of external...

PACB : 9.45 (-2.78%)
PacBio to Report Third Quarter Earnings on November 7 and Host Inaugural Investor Day on November 15

/PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2022 financial results on...

PACB : 9.45 (-2.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 10.12
2nd Resistance Point 9.97
1st Resistance Point 9.71
Last Price 9.45
1st Support Level 9.30
2nd Support Level 9.15
3rd Support Level 8.89

See More

52-Week High 23.87
Fibonacci 61.8% 16.22
Fibonacci 50% 13.86
Fibonacci 38.2% 11.50
Last Price 9.45
52-Week Low 3.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar